<!DOCTYPE html>
<!--
==============================================================================
           "GitHub HTML5 Pandoc Template" v2.1 — by Tristano Ajmone           
==============================================================================
Copyright © Tristano Ajmone, 2017, MIT License (MIT). Project's home:

- https://github.com/tajmone/pandoc-goodies

The CSS in this template reuses source code taken from the following projects:

- GitHub Markdown CSS: Copyright © Sindre Sorhus, MIT License (MIT):
  https://github.com/sindresorhus/github-markdown-css

- Primer CSS: Copyright © 2016-2017 GitHub Inc., MIT License (MIT):
  http://primercss.io/

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
The MIT License 

Copyright (c) Tristano Ajmone, 2017 (github.com/tajmone/pandoc-goodies)
Copyright (c) Sindre Sorhus <sindresorhus@gmail.com> (sindresorhus.com)
Copyright (c) 2017 GitHub Inc.

"GitHub Pandoc HTML5 Template" is Copyright (c) Tristano Ajmone, 2017, released
under the MIT License (MIT); it contains readaptations of substantial portions
of the following third party softwares:

(1) "GitHub Markdown CSS", Copyright (c) Sindre Sorhus, MIT License (MIT).
(2) "Primer CSS", Copyright (c) 2016 GitHub Inc., MIT License (MIT).

Permission is hereby granted, free of charge, to any person obtaining a copy
of this software and associated documentation files (the "Software"), to deal
in the Software without restriction, including without limitation the rights
to use, copy, modify, merge, publish, distribute, sublicense, and/or sell
copies of the Software, and to permit persons to whom the Software is
furnished to do so, subject to the following conditions:

The above copyright notice and this permission notice shall be included in all
copies or substantial portions of the Software.

THE SOFTWARE IS PROVIDED "AS IS", WITHOUT WARRANTY OF ANY KIND, EXPRESS OR
IMPLIED, INCLUDING BUT NOT LIMITED TO THE WARRANTIES OF MERCHANTABILITY,
FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT. IN NO EVENT SHALL THE
AUTHORS OR COPYRIGHT HOLDERS BE LIABLE FOR ANY CLAIM, DAMAGES OR OTHER
LIABILITY, WHETHER IN AN ACTION OF CONTRACT, TORT OR OTHERWISE, ARISING FROM,
OUT OF OR IN CONNECTION WITH THE SOFTWARE OR THE USE OR OTHER DEALINGS IN THE
SOFTWARE.
==============================================================================-->
<html>
<head>
  <meta charset="utf-8" />
  <meta name="generator" content="pandoc" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes" />
  <title>Stroke MeG-CLS-020</title>
  <style type="text/css">
@charset "UTF-8";.markdown-body{-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;color:#24292e;font-family:-apple-system,system-ui,BlinkMacSystemFont,"Segoe UI",Helvetica,Arial,sans-serif,"Apple Color Emoji","Segoe UI Emoji","Segoe UI Symbol";font-size:16px;line-height:1.5;word-wrap:break-word;box-sizing:border-box;min-width:200px;max-width:980px;margin:0 auto;padding:45px}.markdown-body a{color:#0366d6;background-color:transparent;text-decoration:none;-webkit-text-decoration-skip:objects}.markdown-body a:active,.markdown-body a:hover{outline-width:0}.markdown-body a:hover{text-decoration:underline}.markdown-body a:not([href]){color:inherit;text-decoration:none}.markdown-body strong{font-weight:600}.markdown-body h1,.markdown-body h2,.markdown-body h3,.markdown-body h4,.markdown-body h5,.markdown-body h6{margin-top:24px;margin-bottom:16px;font-weight:600;line-height:1.25}.markdown-body h1{font-size:2em;margin:.67em 0;padding-bottom:.3em;border-bottom:1px solid #eaecef}.markdown-body h2{padding-bottom:.3em;font-size:1.5em;border-bottom:1px solid #eaecef}.markdown-body h3{font-size:1.25em}.markdown-body h4{font-size:1em}.markdown-body h5{font-size:.875em}.markdown-body h6{font-size:.85em;color:#6a737d}.markdown-body img{border-style:none}.markdown-body svg:not(:root){overflow:hidden}.markdown-body hr{box-sizing:content-box;height:.25em;margin:24px 0;padding:0;overflow:hidden;background-color:#e1e4e8;border:0}.markdown-body hr::before{display:table;content:""}.markdown-body hr::after{display:table;clear:both;content:""}.markdown-body input{margin:0;overflow:visible;font:inherit;font-family:inherit;font-size:inherit;line-height:inherit}.markdown-body [type=checkbox]{box-sizing:border-box;padding:0}.markdown-body *{box-sizing:border-box}.markdown-body blockquote{margin:0}.markdown-body ol,.markdown-body ul{padding-left:2em}.markdown-body ol ol,.markdown-body ul ol{list-style-type:lower-roman}.markdown-body ol ol,.markdown-body ol ul,.markdown-body ul ol,.markdown-body ul ul{margin-top:0;margin-bottom:0}.markdown-body ol ol ol,.markdown-body ol ul ol,.markdown-body ul ol ol,.markdown-body ul ul ol{list-style-type:lower-alpha}.markdown-body li>p{margin-top:16px}.markdown-body li+li{margin-top:.25em}.markdown-body dd{margin-left:0}.markdown-body dl{padding:0}.markdown-body dl dt{padding:0;margin-top:16px;font-size:1em;font-style:italic;font-weight:600}.markdown-body dl dd{padding:0 16px;margin-bottom:16px}.markdown-body code{font-family:SFMono-Regular,Consolas,"Liberation Mono",Menlo,Courier,monospace}.markdown-body pre{font:12px SFMono-Regular,Consolas,"Liberation Mono",Menlo,Courier,monospace;word-wrap:normal}.markdown-body blockquote,.markdown-body dl,.markdown-body ol,.markdown-body p,.markdown-body pre,.markdown-body table,.markdown-body ul{margin-top:0;margin-bottom:16px}.markdown-body blockquote{padding:0 1em;color:#6a737d;border-left:.25em solid #dfe2e5}.markdown-body blockquote>:first-child{margin-top:0}.markdown-body blockquote>:last-child{margin-bottom:0}.markdown-body table{display:block;width:100%;overflow:auto;border-spacing:0;border-collapse:collapse}.markdown-body table th{font-weight:600}.markdown-body table td,.markdown-body table th{padding:6px 13px;border:1px solid #dfe2e5}.markdown-body table tr{background-color:#fff;border-top:1px solid #c6cbd1}.markdown-body table tr:nth-child(2n){background-color:#f6f8fa}.markdown-body img{max-width:100%;box-sizing:content-box;background-color:#fff}.markdown-body code{padding:.2em 0;margin:0;font-size:85%;background-color:rgba(27,31,35,.05);border-radius:3px}.markdown-body code::after,.markdown-body code::before{letter-spacing:-.2em;content:" "}.markdown-body pre>code{padding:0;margin:0;font-size:100%;word-break:normal;white-space:pre;background:0 0;border:0}.markdown-body .highlight{margin-bottom:16px}.markdown-body .highlight pre{margin-bottom:0;word-break:normal}.markdown-body .highlight pre,.markdown-body pre{padding:16px;overflow:auto;font-size:85%;line-height:1.45;background-color:#f6f8fa;border-radius:3px}.markdown-body pre code{display:inline;max-width:auto;padding:0;margin:0;overflow:visible;line-height:inherit;word-wrap:normal;background-color:transparent;border:0}.markdown-body pre code::after,.markdown-body pre code::before{content:normal}.markdown-body .full-commit .btn-outline:not(:disabled):hover{color:#005cc5;border-color:#005cc5}.markdown-body kbd{box-shadow:inset 0 -1px 0 #959da5;display:inline-block;padding:3px 5px;font:11px/10px SFMono-Regular,Consolas,"Liberation Mono",Menlo,Courier,monospace;color:#444d56;vertical-align:middle;background-color:#fcfcfc;border:1px solid #c6cbd1;border-bottom-color:#959da5;border-radius:3px;box-shadow:inset 0 -1px 0 #959da5}.markdown-body :checked+.radio-label{position:relative;z-index:1;border-color:#0366d6}.markdown-body .task-list-item{list-style-type:none}.markdown-body .task-list-item+.task-list-item{margin-top:3px}.markdown-body .task-list-item input{margin:0 .2em .25em -1.6em;vertical-align:middle}.markdown-body::before{display:table;content:""}.markdown-body::after{display:table;clear:both;content:""}.markdown-body>:first-child{margin-top:0!important}.markdown-body>:last-child{margin-bottom:0!important}.Alert,.Error,.Note,.Success,.Warning{padding:11px;margin-bottom:24px;border-style:solid;border-width:1px;border-radius:4px}.Alert p,.Error p,.Note p,.Success p,.Warning p{margin-top:0}.Alert p:last-child,.Error p:last-child,.Note p:last-child,.Success p:last-child,.Warning p:last-child{margin-bottom:0}.Alert{color:#246;background-color:#e2eef9;border-color:#bac6d3}.Warning{color:#4c4a42;background-color:#fff9ea;border-color:#dfd8c2}.Error{color:#911;background-color:#fcdede;border-color:#d2b2b2}.Success{color:#22662c;background-color:#e2f9e5;border-color:#bad3be}.Note{color:#2f363d;background-color:#f6f8fa;border-color:#d5d8da}.Alert h1,.Alert h2,.Alert h3,.Alert h4,.Alert h5,.Alert h6{color:#246;margin-bottom:0}.Warning h1,.Warning h2,.Warning h3,.Warning h4,.Warning h5,.Warning h6{color:#4c4a42;margin-bottom:0}.Error h1,.Error h2,.Error h3,.Error h4,.Error h5,.Error h6{color:#911;margin-bottom:0}.Success h1,.Success h2,.Success h3,.Success h4,.Success h5,.Success h6{color:#22662c;margin-bottom:0}.Note h1,.Note h2,.Note h3,.Note h4,.Note h5,.Note h6{color:#2f363d;margin-bottom:0}.Alert h1:first-child,.Alert h2:first-child,.Alert h3:first-child,.Alert h4:first-child,.Alert h5:first-child,.Alert h6:first-child,.Error h1:first-child,.Error h2:first-child,.Error h3:first-child,.Error h4:first-child,.Error h5:first-child,.Error h6:first-child,.Note h1:first-child,.Note h2:first-child,.Note h3:first-child,.Note h4:first-child,.Note h5:first-child,.Note h6:first-child,.Success h1:first-child,.Success h2:first-child,.Success h3:first-child,.Success h4:first-child,.Success h5:first-child,.Success h6:first-child,.Warning h1:first-child,.Warning h2:first-child,.Warning h3:first-child,.Warning h4:first-child,.Warning h5:first-child,.Warning h6:first-child{margin-top:0}h1.title,p.subtitle{text-align:center}h1.title.followed-by-subtitle{margin-bottom:0}p.subtitle{font-size:1.5em;font-weight:600;line-height:1.25;margin-top:0;margin-bottom:16px;padding-bottom:.3em}div.line-block{white-space:pre-line}
  </style>
  <style type="text/css">code{white-space: pre;}</style>
  <!--[if lt IE 9]>
    <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.7.3/html5shiv-printshiv.min.js"></script>
  <![endif]-->
</head>
<body>
<article class="markdown-body">
<h1 id="stroke">Stroke</h1>
<h2 id="executive-summary"><em>Executive summary</em></h2>
<h2 id="introduction">Introduction</h2>
<p>A stroke is the sudden loss of neurological function resulting from death of brain tissue from vascular occlusion or rupture.</p>
<p>Stroke is the second leading cause of death globally and the number one cause of functional disability. It is a feared complication of hypertension, diabetes mellitus and heart disease.</p>
<p>The gold standard for stroke treatment includes an early CT scan to rule out bleeding followed by thrombolysis. These are not readily available in The Gambia but should not prevent our patients from receiving the best possible care that is available.</p>
<h3 id="target-users">Target users</h3>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Doctors</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Nurses</p>
</div></li>
</ul>
<h3 id="target-area-of-use">Target area of use </h3>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Gate clinic</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Outpatient department</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Ward</p>
</div></li>
</ul>
<h3 id="key-areas-of-focus-new-additions-changes">Key areas of focus / New additions / Changes </h3>
<p>This guideline covers the diagnoses and management of stroke. It updates the previous guideline on acute stroke care.</p>
<p>Patients suspected to have suffered a stroke should be sent from the Gate Clinic to the ward for urgent review by a doctor.</p>
<p>The ROSIER score can assist the doctor in diagnosis if the presentation is unclear.</p>
<p>For patients presenting in Keneba, refer after emergency care.</p>
<p>Ideally, patients should have a non-contrast cranial CT scan to rule out haemorrhage. Treatment on the ward involves maintenance of hydration, management of intracranial pressure, antithrombotics (if ischaemic), DVT and pressure ulcer prophylaxis, physical therapy and other supportive care. In addition, patients with suspected SAH require sedation, analgesia, laxatives and possible early neurosurgical referral.</p>
<p>Post-discharge care should be planned in consultation with the patient and/or caregivers. This may include palliative care in patients with severe functional disability.</p>
<h2 id="limitations">Limitations</h2>
<p>CT scan and rehabilitation services may not be readily accessible to most patients. Thrombolysis for stroke is currently unavailable in The Gambia.</p>
<h2 id="presenting-symptoms-and-signs">Presenting symptoms and signs</h2>
<p>Stroke typically presents as sudden, rapidly peaking loss of neurological function. A history of sudden limb weakness, slurring of speech or visual deficits suggests a stroke or, if resolved within 24 hours, a transient ischaemic attack. Rarely, a stroke may present with only paraesthesia, balance problems or language problems.</p>
<p>Ask for head trauma within the past 3 months.</p>
<p>If any of coma, neck stiffness, seizures, diastolic blood pressure &gt; 110 mmHg, vomiting, or headache is also present, the patient is more likely to have had a haemorrhagic type of stroke. A history of sudden severe headache and neck stiffness is in keeping with subarachnoid haemorrhage.</p>
<p>A history of only loss of consciousness or seizures suggests an alternative diagnosis.</p>
<h2 id="examination-findings">Examination findings</h2>
<p>Assess airway, breathing and circulation. Check the observations (HR, BP, RR, O<sub>2</sub> saturations, Temperature).</p>
<p>Assess consciousness, then orientation in time, place and person. Observe for confusion and difficulty producing or understanding speech.</p>
<p>Check for neck stiffness which suggests subarachnoid haemorrhage.</p>
<p>Assess the pupils, eye movements and facial symmetry. If patient is conscious, ask them to protrude their tongue.</p>
<p>Assess tone, power and reflexes across the limbs.</p>
<p>Observe the gait if the patient is able to walk.</p>
<p>Listen over the heart for rhythm, murmurs and over the neck for carotid bruit.</p>
<h2 id="investigations">Investigations</h2>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Blood glucose as soon as possible (Both hypo- and hyperglycaemia are stroke mimics. They also worsen stroke outcome)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>CT Scan of the brain without contrast to rule out haemorrhage. This should be done same day if stable or next day (if available and affordable).</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Full Blood Count</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>ESR (helps exclude vasculitis in younger patients)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Electrolytes, Urea and Creatinine</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Urinalysis</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>ECG (rule out atrial fibrillation)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>CXR</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Sepsis screen (if fever develops)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Clotting profile (if previously on warfarin)</p>
</div></li>
</ul>
<h2 id="aim-to-have-acted-on-the-results-for-the-above-tests-excluding-cultures-in-less-than-four-hours.">Aim to have acted on the results for the above tests (excluding cultures) in less than four hours.</h2>
<h2 id="management">Management </h2>
<h3 id="management-in-gate-clinic">Management in Gate Clinic</h3>
<p>All patients with features of a possible stroke (recent onset of facial weakness, limb weakness or speech problems) should be referred immediately to the ward for urgent review by a doctor.</p>
<h3 id="management-on-the-ward">Management on the Ward</h3>
<p><span class="underline">Assessment:</span></p>
<p>Use the ROSIER (Recognition of Stroke in the Emergency Room) score if uncertain of the diagnosis of stroke</p>
<table>
<thead>
<tr class="header">
<th><strong>Feature</strong></th>
<th><strong>Score</strong></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Loss of consciousness or syncope</td>
<td>-1</td>
</tr>
<tr class="even">
<td>Seizure activity</td>
<td>-1</td>
</tr>
<tr class="odd">
<td>Asymmetric facial weakness*</td>
<td>+1</td>
</tr>
<tr class="even">
<td>Asymmetric arm weakness*</td>
<td>+1</td>
</tr>
<tr class="odd">
<td>Asymmetric leg weakness*</td>
<td>+1</td>
</tr>
<tr class="even">
<td>Speech disturbance*</td>
<td>+1</td>
</tr>
<tr class="odd">
<td>Visual field defect*</td>
<td>+1</td>
</tr>
</tbody>
</table>
<div data-custom-style="List Paragraph">
<p>*of recent sudden onset or noticed on waking from sleep</p>
</div>
<p>If the total ROSIER score is less than 1, a diagnosis of stroke is unlikely.</p>
<p>Consider other diagnosis if the patient is young, has gradual progression over days, is febrile or has papilloedema.</p>
<p><span class="underline">Treatment:</span></p>
<p><span class="underline">Starting at admission:</span></p>
<ol type="1">
<li><div data-custom-style="List Paragraph">
<p>Hydrate initially with <strong>IV normal saline</strong>.</p>
</div>
<ol type="a">
<li><div data-custom-style="List Paragraph">
<p>Nothing by mouth if dysarthric. Start on NG tube. Repeat <strong>swallow test</strong> daily for conscious patients.</p>
</div></li>
</ol></li>
<li><div data-custom-style="List Paragraph">
<p>If there are signs of <strong>raised ICP,</strong> give IV furosemide 40 mg bolus and IV mannitol 0.5 g/kg given over 20 minutes 4 - 6 hourly.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Antithrombotics: If CT scan rules out haemorrhage, commence <strong>oral aspirin</strong> at 300 mg daily for 4 weeks. For patients without a CT scan but unlikely to have haemorrhagic stroke, start aspirin on day 2 at 150 mg daily for 2 weeks. Reduce to 75 mg daily subsequently.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>For suspected vasculitis (e.g raised ESR), consider starting 1 mg per kg prednisolone.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>For stroke patients presenting in Keneba, commence emergency care and refer immediately.</p>
</div></li>
</ol>
<p><span class="underline">Starting after 24 hours:</span></p>
<ol start="6" type="1">
<li><div data-custom-style="List Paragraph">
<p><strong>DVT prophylaxis</strong> with <strong>heparin</strong> after 2 days for immobile patients if hemorrhage is ruled out or unlikely.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p><strong>Early mobilization</strong> of the patient is encouraged but minimize within first 24 hours.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p><strong>Statins</strong> should be commenced after 48 hours if patient is able to obtain the drug.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Treat <strong>recurrent seizures</strong> with oral carbamazepine or valproate.</p>
</div></li>
</ol>
<p><span class="underline">Ongoing supportive care</span></p>
<ol start="10" type="1">
<li><div data-custom-style="List Paragraph">
<p><strong>Supplemental Oxygen</strong> should be given for patients with oxygen saturations below 94%.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Keep <strong>systolic BP</strong> below 180 mmHg with oral antihypertensives. Consider IV labetalol if systolic blood pressure is &gt;220 mmHg</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Maintain <strong>blood glucose</strong> between 7.7 – 10 mmol/l. Hypoglycaemia should be identified and treated promptly. Hyperglycaemia may require insulin therapy as discussed in the Diabetes Mellitus guideline.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Maintain normal <strong>body temperature</strong>. Fever &gt;37.5°C should be treated with paracetamol. Search for possible infections and do sepsis screening. Avoid indwelling catheters if feasible, otherwise monitor daily.</p>
</div></li>
</ol>
<p><span class="underline">SAH:</span></p>
<ol start="14" type="1">
<li><div data-custom-style="List Paragraph">
<p>For suspected or confirmed subarachnoid haemorrhage,</p>
</div>
<ol type="a">
<li><div data-custom-style="List Paragraph">
<p>Keep systolic BP below 130 mmHg with a calcium channel blocker but avoid hypotension</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Lactulose suspension to keep stools soft (prevents straining and raised ICP)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Oral diazepam for light sedation</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Analgesics</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Consider early referral for neurosurgical management especially for unconscious patients or sudden deterioration</p>
</div></li>
</ol></li>
</ol>
<h3 id="discharge-planning-and-post-discharge-care">Discharge planning and Post-Discharge Care</h3>
<p>Discharge planning should involve the patient, their caregivers at home and the clinical team. Stroke patients should be discharged home when agreed-upon achievable goals of inpatient care have been reached and the home environment made safe. Patients with severe residual brain injury from stroke may require palliative care.</p>
<p>Assess functional independence at discharge</p>
<p>Plan safe care at home e.g sturdy arm-chairs resting against walls, wheelchairs, relocate patient to a ground-floor bedroom, install hand-holds on walls.</p>
<p>Explain stroke risk factors and prescriptions to the patient and caregivers.</p>
<p>Patients with persistent swallowing difficulties may be fed with thickened fluids if tolerated. For patients requiring nasogastric feeding, discuss feasibility of a PEG tube insertion.</p>
<p>Patient should be referred for physical and psychological rehabilitation services. Regardless of clinical recovery, patients with stroke should be advised not to drive for at least one month post-discharge.</p>
<p>Schedule first follow-up visit for 4 weeks after discharge but advise caregivers to present early if they notice any deterioration in the patient’s state.</p>
<h2 id="key-issues-for-nursing-care">Key Issues for Nursing care</h2>
<p>Monitor vital signs every 4 hours. Call the doctor if:</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Temperature &gt; 37.5</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Blood glucose &lt; 6 mmol/l or &gt; 10 mmol/l</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Systolic blood pressure &lt; 140 or &gt; 180 mmHg</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>GCS drops by 1 point compared to last observation</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Oxygen saturation &lt; 95%</p>
</div></li>
</ul>
<p>Nurse in 30 degrees head up position with head in midline</p>
<p>Two-hourly turning and surveillance for pressure ulcers if unconscious/immobile</p>
<p>Suction oral cavity and airway as needed if unconscious</p>
<p>Strict fluid charts</p>
<p>Strict bed rest if SAH is suspected</p>
<h2 id="references">References</h2>
<p>Prasad K, Kaul S, Padma MV, Gorthi SP, Khurana D, Bakshi A. Stroke management. Ann Indian Acad Neurol. 2011;14(Suppl 1):S82-96.</p>
<p>Berkowitz AL. Managing acute stroke in low-resource settings. Bull World Health Organ. 2016;94(7):554-6.</p>
<p>Stroke and transient ischaemic attack in over 16s: diagnosis and initial management. NICE Guideline. March 2017</p>
<p>Nor AM, Davis J, Sen B, Shipsey D, Louw SJ, Dyker AG, Davis M, Ford GA. The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.Lancet Neurol. 2005 Nov;4(11):727-34.</p>
<p>Medscape. Subarachnoid haemorrhage. Available at: <a href="https://emedicine.medscape.com/article/1164341-overview"><span data-custom-style="Hyperlink">https://emedicine.medscape.com/article/1164341-overview</span></a> Accessed: 9<sup>th</sup> January 2019</p>
<table>
<thead>
<tr class="header">
<th><strong>Written by:</strong></th>
<th>Name: Fatai Akemokwe</th>
<th>Date: 09 January 2019</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Reviewed by:</strong></td>
<td>Name: Karen Forrest</td>
<td>Date: 14 January 2019</td>
</tr>
<tr class="even">
<td><strong>Version:</strong></td>
<td><strong>Change history:</strong></td>
<td><strong>Review due date:</strong></td>
</tr>
<tr class="odd">
<td>1.0</td>
<td>New document</td>
<td></td>
</tr>
<tr class="even">
<td>2.0</td>
<td>Previous guideline was updated and transferred onto the new template</td>
<td>31 January 2021</td>
</tr>
<tr class="odd">
<td>2.1</td>
<td>Executive summary added</td>
<td>31 January 2021</td>
</tr>
<tr class="even">
<td>Review Comments (<em>if applicable)</em></td>
<td></td>
<td></td>
</tr>
</tbody>
</table>
</article>
</body>
</html>
